BlackRock Health Sciences Term Trust
BMEZ US09260E1055
BlackRock Health Sciences Trust II is a closed-ended management investment company. The investment objective is to provide total return through a combination of current income and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of energy and natural resources companies and equity derivatives with exposure to the energy and natural resources industry.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -8% | -33% | 3% | 7% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Mcclements Kyle |
16.49 USD |
609 Sold |
10,046 USD |
31/01/2025 | 31/01/2025 |
| Xie H Erin |
16.49 USD |
14,883 Sold |
245,414 USD |
31/01/2025 | 31/01/2025 |
| Liu Xiang |
16.49 USD |
225 Sold |
3,712 USD |
31/01/2025 | 31/01/2025 |
| Accettella Christopher |
16.49 USD |
168 Sold |
2,774 USD |
31/01/2025 | 31/01/2025 |
| Xie H Erin |
17.93 USD |
6,369 Sold |
114,203 USD |
31/01/2024 | 31/01/2024 |
| Accettella Christopher |
15.17 USD |
1,190 Bought |
18,052 USD |
11/01/2024 | 11/01/2024 |
| Mcclements Kyle |
14.77 USD |
550 Bought |
8,124 USD |
27/12/2023 | 27/12/2023 |
| Mcclements Kyle |
14.78 USD |
450 Bought |
6,651 USD |
27/12/2023 | 27/12/2023 |